Published in HPB (Oxford) on March 22, 2016
Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery (2000) 2.55
Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg (2009) 2.44
Measured versus estimated total liver volume to preoperatively assess the adequacy of the future liver remnant: which method should we use? Ann Surg (2013) 2.39
Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections. HPB (Oxford) (2015) 0.93
Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment. J Hepatol (2016) 0.80
Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments? Hepatobiliary Surg Nutr (2017) 0.75
Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries. Ann Surg Oncol (2017) 0.75
Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma. Surg Oncol (2021) 0.75
Laparoscopic Management of Gallbladder Cancer: A Stepwise Approach. Ann Surg Oncol (2016) 0.75
Local Therapy for Colorectal Liver Metastases: Establishing Today's Level of Evidence and Defining Tomorrow's Roadmap. J Natl Cancer Inst (2017) 0.75
Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol (2017) 0.75
Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford) (2017) 0.75
Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol (2020) 0.75
Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases. Ann Surg Oncol (2017) 0.75
Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy. Ann Surg Oncol (2015) 0.75
Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection. J Gastrointest Surg (2016) 0.75
Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases. Ann Surg Oncol (2017) 0.75
Tips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy. Surg Endosc (2017) 0.75
Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter? Ann Surg Oncol (2017) 0.75
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol (2017) 0.75
Laparoscopic Glissonean Pedicle Transection (Takasaki) for Negative Fluorescent Counterstaining of Segment 6. Ann Surg Oncol (2016) 0.75
Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection. Ann Surg Oncol (2017) 0.75
Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma. Ann Surg Oncol (2017) 0.75
Effective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer. Ann Surg Oncol (2017) 0.75
AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol (2021) 0.75